New Brunswick has seen its first case of a rare blood clot experienced after a dose of the AstraZeneca vaccine, Dr. Jennifer Russel, the chief medical health officer, has confirmed.
The individual received treatment and has recovered, Russell said at a live-streamed COVID-19 update on Tuesday afternoon.
She noted that the individual, who is between age 30 and 39, received the AstraZeneca-Covishield vaccine in mid-March prior to a recommendation from the National Advisory Committee on Immunization not to administer the vaccine to people under age 55.